Future and Challenges of the Pharmaceutical Industry

14 November 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

21 December 2017

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017

Europe needs change to drive added value

15 September 2017

European report calms common concerns

15 September 2017

Europäer zahlen zu viel für Pillen

18 July 2017

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017